LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p/programmed death-ligand 1 axis

被引:94
|
作者
Wei, Shuquan [1 ]
Wang, Kangwei [2 ]
Huang, Xiaomei [1 ]
Zhao, Zhuxiang [1 ]
Zhao, Ziwen [1 ]
机构
[1] South China Univ Technol, Affiliated Hosp 2, Dept Pulm & Crit Care Med, Guangzhou Peoples Hosp 1, 1 Panfu Rd, Guangzhou 510180, Guangdong, Peoples R China
[2] South China Univ Technol, Affiliated Hosp 2, Dept Pathol, Guangzhou Peoples Hosp 1, Guangzhou, Guangdong, Peoples R China
关键词
lncRNA MALAT1; miR-200a-3p; NSCLC; PD-L1; LONG NONCODING RNA; PROLIFERATION; PD-L1; IMMUNOTHERAPY; EXPRESSION; PATHWAY;
D O I
10.1177/2058738419859699
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This study was to investigate the expression correlation between long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 (lncRNA MALAT1), miR-200a-3p and programmed death-ligand 1 (PD-L1) in non-small cell lung cancer (NSCLC), and their roles in NSCLC. Real-time polymerase chain reaction (PCR) was performed to detect the expressions of MALAT1, miR-200a-3p and PD-L1 in NSCLC tissues and cells for the correlation analysis. The starBase and Targetscan databases were used to predict the binding sites between MALAT1 and miR-200a-3p, and miR-200a-3p and PD-L1, respectively. The targeting relationship between MALAT1 and miR-200a-3p, and miR-200a-3p and PD-L1 were further verified by real-time PCR and dual luciferase reporter gene assay. Cell proliferation was monitored by CCK8 and colony formation assays. The apoptosis was detected using flow cytometry. Wound healing assay and transwell assay were conducted to determine cell migration and invasion. In this study, we demonstrated that in NSCLC tissues, the expression level of MALAT1 was negatively correlated with that of miR-200a-3p, while positively correlated with PD-L1. Besides, MALAT1 promoted proliferation, mobility, migration, and invasion of NSCLC cells via sponging miR-200a-3p. PD-L1 was validated as a target of miR-200a-3p, and indirectly modulated by MALAT1. In conclusion, LncRNA MALAT1 facilitates the progression of NSCLC by modulating miR-200a-3p/PDL1 axis.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Lymphocyte activation gene-3 is associated with programmed death-ligand 1 and programmed cell death protein 1 in small cell lung cancer
    Sun, Hui
    Dai, Jiawei
    Zhao, Lishu
    Zhu, Jun
    Wang, Hao
    Chen, Peixin
    Lu, Hui
    Chen, Qiankun
    Zhang, Zhemin
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (18)
  • [32] LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis
    Luo, Xiping
    Zhou, Juan
    Quan, Lingli
    Liang, Yanchao
    Chen, Fangwei
    Liu, Shuangbo
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (11)
  • [33] Programmed Death-ligand 1 Expression Analysis for Non-small Cell Lung Cancer in Tissues Sampled Using Different Methods
    Urer, Halide Nur
    Gunluoglu, Mehmet Zeki
    Cansever, Levent
    Bedirhan, Mehmet Ali
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2020, 58 (02): : 135 - 141
  • [34] Programmed Death-Ligand 1 of Cytology Specimens as a Promising Method for Maker Evaluation in Patients of Non-Small Cell Lung Cancer
    Dong, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S923 - S923
  • [35] Petals and Thorns in Programmed Death-Ligand 1 Testing: Is All Non-Small Cell Lung Cancer Diagnostic Material Suitable?
    Bravaccini, Sara
    Bronte, Giuseppe
    CANCER CYTOPATHOLOGY, 2018, 126 (09) : 817 - 818
  • [36] Clinicopathological analysis and prognostic significance of programmed cell death-ligand 1 protein and mRNA expression in non-small cell lung cancer
    Kim, Hyojin
    Kwon, Hyun Jung
    Park, Soo Young
    Park, Youngmi
    Park, Eunhyang
    Chung, Jin-Haeng
    PLOS ONE, 2018, 13 (06):
  • [37] LncRNA MALAT1 Regulating Lung Carcinoma Progression via the miR-491-5p/UBE2C Axis
    Dai, Juanjuan
    Zhou, Ning
    Wu, Rui
    Du, Jing
    Miao, Shuang
    Gong, Kaikai
    Yang, Lijuan
    Chen, Weiwei
    Li, Xuelin
    Li, Chen
    Wu, Yan
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [38] Use of the 22C3 anti-programmed death-ligand 1 antibody to determine programmed death-ligand 1 expression in cytology samples obtained from non-small cell lung cancer patients
    Ilie, Marius
    Juco, Jonathan
    Huang, Lingkang
    Hofman, Veronique
    Khambata-Ford, Shirin
    Hofman, Paul
    CANCER CYTOPATHOLOGY, 2018, 126 (04) : 264 - 274
  • [39] Programmed Death-ligand 1 Expression With Clone 22C3 in Non-small Cell Lung Cancer: A Single Institution Experience
    Takeda, Maiko
    Kasai, Takahiko
    Naito, Maiko
    Tamiya, Akihiro
    Taniguchi, Yoshihiko
    Saijo, Nobuhiko
    Naoki, Yoko
    Okishio, Kyoichi
    Shimizu, Shigeki
    Kojima, Kensuke
    Nagoya, Akihiro
    Sakamoto, Tetsuki
    Utsumi, Tomoki
    Yoon, Hyung-Eun
    Matsumura, Akihide
    Atagi, Shinji
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2019, 13
  • [40] LncRNA MALAT1 regulates growth of carcinoma of the lung through modulating miR-338-3p/PYCR2 axis
    Geng, Yang
    Chen, Pengfei
    Zhang, Lei
    Li, Xiaojun
    Song, Chao
    Wei, Xueting
    Gong, Huiyuan
    CELLULAR AND MOLECULAR BIOLOGY, 2023, 69 (04) : 133 - 140